113 related articles for article (PubMed ID: 17326783)
1. No recurrence of Kaposi's sarcoma in a case of renal retransplantation under a calcineurin inhibitor free immunosuppressive regimen: first report.
Segoloni GP; Giraudi R; Messina M; Rossetti M; Biancone L; Leonardi G; Piccoli GB; Magnano A; Gai M
Transpl Int; 2007 Apr; 20(4):395-6. PubMed ID: 17326783
[No Abstract] [Full Text] [Related]
2. Kaposi's sarcoma after renal transplantation.
Gutiérrez-Dalmau A; Campistol JM
N Engl J Med; 2005 Aug; 353(8):846-7; author reply 846-7. PubMed ID: 16124128
[No Abstract] [Full Text] [Related]
3. Sirolimus to replace calcineurin inhibitors? Too early yet.
Cravedi P; Ruggenenti P; Remuzzi G
Lancet; 2009 Apr; 373(9671):1235-6. PubMed ID: 19362662
[No Abstract] [Full Text] [Related]
4. Kaposi's sarcoma in the early post-transplant period in a kidney transplant recipient.
Ercan Z; Demir ME; Merhametsiz O; Yayar O; Ulas T; Ayli MD
Nefrologia; 2013 Nov; 33(6):861-2. PubMed ID: 24241380
[No Abstract] [Full Text] [Related]
5. A novel immunosuppressive agent, sirolimus, in the treatment of Kaposi's sarcoma in a renal transplant recipient.
Yilmaz R; Akoglu H; Kirkpantur A; Kilickap S; Arici M; Altun B; Aki T; Erdem Y; Yasavul U; Turgan C
Ren Fail; 2007; 29(1):103-5. PubMed ID: 17365918
[TBL] [Abstract][Full Text] [Related]
6. Kaposi's sarcoma after renal transplantation--disappearance after reduction of immunosuppression and reappearance 7 years later after start of mycophenolate mofetil treatment.
Gómez E; Aguado S; Rodríguez M; Alvarez-Grande J
Nephrol Dial Transplant; 1998 Dec; 13(12):3279-80. PubMed ID: 9870518
[No Abstract] [Full Text] [Related]
7. Sirolimus for Kaposi's sarcoma in renal-transplant recipients.
Stallone G; Schena A; Infante B; Di Paolo S; Loverre A; Maggio G; Ranieri E; Gesualdo L; Schena FP; Grandaliano G
N Engl J Med; 2005 Mar; 352(13):1317-23. PubMed ID: 15800227
[TBL] [Abstract][Full Text] [Related]
8. [Calcineurin-inhibitor-free immunosuppression in early renal transplantation].
Olea T; Jiménez C; Escuín F; García de Miguel A; Ros S; Sanz A
Nefrologia; 2004; 24 Suppl 3():11-5. PubMed ID: 15219061
[TBL] [Abstract][Full Text] [Related]
9. Reccurence of Kaposi's sarcoma after increased exposure to sirolimus.
Boratyńska M; Zmonarski SC; Klinger M
Int Immunopharmacol; 2006 Dec; 6(13-14):2018-22. PubMed ID: 17161356
[TBL] [Abstract][Full Text] [Related]
10. Regression of post-transplant Kaposi's sarcoma using sirolimus.
Kolhe N; Mamode N; Van der Walt J; Pattison J
Int J Clin Pract; 2006 Nov; 60(11):1509-12. PubMed ID: 16787440
[TBL] [Abstract][Full Text] [Related]
11. Resolution of diffuse skin and systemic Kaposi's sarcoma in a renal transplant recipient after introduction of everolimus: a case report.
Detroyer D; Deraedt K; Schöffski P; Hauben E; Lagrou K; Naesens M; Delforge ML; Kuypers D
Transpl Infect Dis; 2015 Apr; 17(2):303-7. PubMed ID: 25645490
[TBL] [Abstract][Full Text] [Related]
12. Conversion to sirolimus: a successful treatment for posttransplantation Kaposi's sarcoma.
Campistol JM; Gutierrez-Dalmau A; Torregrosa JV
Transplantation; 2004 Mar; 77(5):760-2. PubMed ID: 15021843
[TBL] [Abstract][Full Text] [Related]
13. Localized Kaposi's sarcoma in a patient with pemphigus vulgaris.
Avalos-Peralta P; Herrera A; Ríos-Martín JJ; Pérez-Bernal AM; Moreno-Ramírez D; Camacho F
J Eur Acad Dermatol Venereol; 2006 Jan; 20(1):79-83. PubMed ID: 16405614
[TBL] [Abstract][Full Text] [Related]
14. No recurrence of posttransplantation Kaposi's sarcoma three years after renal retransplantation.
Euvrard S; Kanitakis J; Bosshard S; Lebbé C; Garnier JL; Touraine JL; Claudy A
Transplantation; 2002 Jan; 73(2):297-9. PubMed ID: 11821747
[TBL] [Abstract][Full Text] [Related]
15. Molecularly targeted therapy for Kaposi's sarcoma in a kidney transplant patient: case report, "what worked and what did not".
Volkow P; Zinser JW; Correa-Rotter R
BMC Nephrol; 2007 Mar; 8():6. PubMed ID: 17386117
[TBL] [Abstract][Full Text] [Related]
16. Posttransplantation Kaposi sarcoma-experience in a patient receiving FK-506 and MMF.
Chiang Y; Chu S; Chuang C
Transplant Proc; 2003 Feb; 35(1):258. PubMed ID: 12591389
[No Abstract] [Full Text] [Related]
17. Experience with sirolimus for calcineurin minimization/elimination in pancreas-after-kidney transplantation.
Gautam A; Morrissey PE; Gohh R; Yango A; Monaco AP
Transplant Proc; 2005 Oct; 37(8):3542-3. PubMed ID: 16298654
[TBL] [Abstract][Full Text] [Related]
18. Early steroid withdrawal therapy in renal transplant recipients: a steroid-free sirolimus and CellCept-based calcineurin inhibitor-minimization protocol.
Jaber JJ; Feustel PJ; Elbahloul O; Conti AD; Gallichio MH; Conti DJ
Clin Transplant; 2007; 21(1):101-9. PubMed ID: 17302598
[TBL] [Abstract][Full Text] [Related]
19. Leflunomide with low-dose everolimus for treatment of Kaposi's sarcoma in a renal allograft recipient.
Basu G; Mohapatra A; Manipadam MT; Mani SE; John GT
Nephrol Dial Transplant; 2011 Oct; 26(10):3412-5. PubMed ID: 21775763
[TBL] [Abstract][Full Text] [Related]
20. Posttransplant Kaposi sarcoma and risk for deep venous thrombosis: a case-control study.
Pliquett RU; Schöfer H; Asbe-Vollkopf A; Hauser IA; Scheuermann EH; Kachel HG
Transplantation; 2011 Feb; 91(4):e21-2. PubMed ID: 21304394
[No Abstract] [Full Text] [Related]
[Next] [New Search]
